Video Experimental Relacionado

Updated: Jun 15, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Tratamiento del cáncer de próstata con alfa-bromo-alfa beta. El beta-trifeniletileno (Y59) también se conoce como

M BERGER, N P BUN-HOI

    Lancet (London, England)
    |March 19, 2010
    PubMed
    Resumen

    No abstract available in PubMed .

    Palabras clave:
    Compuestos de bromuro y bromina/terapia.PROSTATA / cáncer de próstata.

    Más Videos Relacionados

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    Videos de Conceptos Relacionados

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...